Differential effects of class I isoform histone deacetylase depletion and enzymatic inhibition by belinostat or valproic acid in HeLa cells

Molecular Cancer

Volumn 7, Issue , 2008, Pages

  Dejligbjerg, Marielle ^a,b   Grauslund, Morten ^a,b   Litman, Thomas ^c   Collins, Laura ^b   Qian, Xiaozhong ^d   Jeffers, Michael ^d   Lichenstein, Henri ^d   Jensen, Peter Buhl ^b,e   Sehested, Maxwell ^a,b  

^a Rigshospitalet   (Denmark)

^b BioAlliance Pharma   (France)

^c Exiqon AS   (Denmark)

^d CURAGEN CORPORATION   (United States)

^e FINSEN LABORATORY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BELINOSTAT; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE 3; HISTONE DEACETYLASE INHIBITOR; UNCLASSIFIED DRUG; VALPROIC ACID; 3 PHENYLSULFAMOYLCINNAMOHYDROXAMIC ACID; ENZYME INHIBITOR; HDAC1 PROTEIN, HUMAN; HDAC3 PROTEIN, HUMAN; HISTONE DEACETYLASE; HISTONE DEACETYLASE-2; HYDROXAMIC ACID; ISOPROTEIN; REPRESSOR PROTEIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER RESISTANCE; CELL SPECIFICITY; CELL STRAIN HCT116; CELL STRAIN MCF 7; CONTROLLED STUDY; DRUG RESPONSE; DRUG SELECTIVITY; DRUG TARGETING; ENZYME INHIBITION; GENE EXPRESSION PROFILING; HELA CELL; HUMAN; HUMAN CELL; MITOSIS INHIBITION; PROTEIN DEPLETION; TRANSCRIPTION REGULATION; CELL SURVIVAL; DRUG ANTAGONISM; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM;

CELL SURVIVAL; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HELA CELLS; HISTONE DEACETYLASES; HUMANS; HYDROXAMIC ACIDS; PROTEIN ISOFORMS; REPRESSOR PROTEINS; TRANSCRIPTION, GENETIC; VALPROIC ACID;

EID: 53149153902     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-7-70     Document Type: Article

References (41)

1. Bolden JE Peart MJ Johnstone RW Anticancer activities of histone deacetylase inhibitors Nat Rev Drug Discov 2006, 5:769-784 10.1038/ nrd2133 16955068
2. Gallinari P DiMarco S Jones P Pallaoro M Steinkuhler C HDACs, histone deacetylation and gene transcription: From molecular biology to cancer therapeutics Cell Res 2007, 17:195-211 17325692
3. Strahl BD Allis CD The language of covalent histone modifications Nature 2000, 403:41-45 10.1038/47412 10638745
4. Minucci S Pelicci PG Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer Nat Rev Cancer 2006, 6:38-51 10.1038/nrc1779 16397526
5. Bernstein BE Tong JK Schreiber SL Genomewide studies of histone deacetylase function in yeast Proc Natl Acad Sci USA 2000, 97:13708-13713 17640 11095743 10.1073/pnas.250477697
6. Glaser KB Li J Staver MJ Wei RQ Albert DH Davidsen SK Role of class I and class II histone deacetylases in carcinoma cells using siRNA Biochem Biophys Res Commun 2003, 310:529-536 10.1016/j.bbrc.2003.09.043 14521942
7. Khabele D Son DS Parl AK Goldberg GL Augenlicht LH Mariadason JM Rice VM Drug-Induced Inactivation or Gene Silencing of Class I Histone Deacetylases Suppresses Ovarian Cancer Cell Growth: Implications for Therapy Cancer Biol Ther 2007, 6:795-801 17387270
8. Lagger G O'Carroll D Rembold M Khier H Tischler J Weitzer G Schuettengruber B Hauser C Brunmeir R Jenuwein T Seiser C Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression EMBO J 2002, 21:2672-2681 126040 12032080 10.1093/ emboj/21.11.2672
9. Senese S Zaragoza K Minardi S Muradore I Ronzoni S Passafaro A Bernard L Draetta GF Alcalay M Seiser C Chiocca S A role for histone deacetylase 1 in human tumor cell proliferation Mol Cell Biol 2007, 27:4784-4795 1951481 17470557 10.1128/MCB.00494-07
10. Huang BH Laban M Leung CH Lee L Lee CK Salto-Tellez M Raju GC Hooi SC Inhibition of histone deacetylase 2 increases apoptosis and p21Cip1/WAF1 expression, independent of histone deacetylase 1 Cell Death Differ 2005, 12:395-404 10.1038/sj.cdd.4401567 15665816
11. Zhu P Huber E Kiefer F Gottlicher M Specific and redundant functions of histone deacetylases in regulation of cell cycle and apoptosis Cell Cycle 2004, 3:1240-1242 15477762
12. Waltregny D Glenisson W Tran SL North BJ Verdin E Colige A Castronovo V Histone deacetylase HDAC8 associates with smooth muscle alpha-actin and is essential for smooth muscle cell contractility FASEB J 2005, 19:966-968 15772115
13. Vannini A Volpari C Filocamo G Casavola EC Brunetti M Renzoni D Chakravarty P Paolini C De FR Gallinari P Steinkuhler C DiMarco S Crystal structure of a eukaryotic zinc-dependent histone deacetylase, human HDAC8, complexed with a hydroxamic acid inhibitor Proc Natl Acad Sci USA 2004, 101:15064-15069 524051 15477595 10.1073/pnas.0404603101
14. Verdin E Dequiedt F Kasler HG Class II histone deacetylases: Versatile regulators Trends Genet 2003, 19:286-293 10.1016/S0168-9525(03)00073-8 12711221
15. Haggarty SJ Koeller KM Wong JC Grozinger CM Schreiber SL Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation Proc Natl Acad Sci USA 2003, 100:4389-4394 153564 12677000 10.1073/pnas.0430973100
16. Choi JH Kwon HJ Yoon BI Kim JH Han SU Joo HJ Kim DY Expression profile of histone deacetylase 1 in gastric cancer tissues Jpn J Cancer Res 2001, 92:1300-1304 11749695
17. Sakuma T Uzawa K Onda T Shiiba M Yokoe H Shibahara T Tanzawa H Aberrant expression of histone deacetylase 6 in oral squamous cell carcinoma Int J Oncol 2006, 29:117-124 16773191
18. Sasaki H Moriyama S Nakashima Y Kobayashi Y Kiriyama M Fukai I Yamakawa Y Fujii Y Histone deacetylase 1 mRNA expression in lung cancer Lung Cancer 2004, 46:171-178 10.1016/j.lungcan.2004.03.021 15474665
19. Wilson AJ Byun DS Popova N Murray LB L'Italien K Sowa Y Arango D Velcich A Augenlicht LH Mariadason JM Histone deacetylase 3 (HDAC3) and other class I HDACs regulate colon cell maturation and p21 expression and are deregulated in human colon cancer J Biol Chem 2006, 281:13548-13558 10.1074/jbc.M510023200 16533812
20. Zhang Z Yamashita H Toyama T Sugiura H Omoto Y Ando Y Mita K Hamaguchi M Hayashi S Iwase H HDAC6 expression is correlated with better survival in breast cancer Clin Cancer Res 2004, 10:6962-6968 10.1158/ 1078-0432.CCR-04-0455 15501975
21. Zhu P Martin E Mengwasser J Schlag P Janssen KP Gottlicher M Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis Cancer Cell 2004, 5:455-463 10.1016/S1535-6108(04)00114-X 15144953
22. Zimmermann S Kiefer F Prudenziati M Spiller C Hansen J Floss T Wurst W Minucci S Gottlicher M Reduced body size and decreased intestinal tumor rates in HDAC2-mutant mice Cancer Res 2007, 67:9047-9054 10.1158/ 0008-5472.CAN-07-0312 17909008
23. Fraga MF Ballestar E Villar-Garea A Boix-Chornet M Espada J Schotta G Bonaldi T Haydon C Ropero S Petrie K Iyer NG Perez-Rosado A Calvo E Lopez JA Cano A Calasanz MJ Colomer D Piris MA Ahn N Imhof A Caldas C Jenuwein T Esteller M Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer Nat Genet 2005, 37:391-400 10.1038/ng1531 15765097
24. Glaser KB Staver MJ Waring JF Stender J Ulrich RG Davidsen SK Gene expression profiling of multiple histone deacetylase (HDAC) inhibitors: defining a common gene set produced by HDAC inhibition in T24 and MDA carcinoma cell lines Mol Cancer Ther 2003, 2:151-163 12589032
25. Gray SG Qian CN Furge K Guo X Teh BT Microarray profiling of the effects of histone deacetylase inhibitors on gene expression in cancer cell lines Int J Oncol 2004, 24:773-795 15010814
26. Khan N Jeffers M Kumar S Hackett C Boldog F Khramtsov N Qian X Mills E Berghs SC Carey N Finn PW Collins LS Tumber A Ritchie JW Jensen PB Lichenstein HS Sehested M Determination of the class and isoform selectivity of small molecule HDAC inhibitors Biochem J 2007, 409:581-589 10.1042/BJ20070779 17868033
27. Glaser KB HDAC inhibitors: Clinical update and mechanism-based potential Biochem Pharmacol 2007, 74:659-671 10.1016/j.bcp.2007.04.007 17498667
28. Takami Y Nakayama T N-terminal region, C-terminal region, nuclear export signal, and deacetylation activity of histone deacetylase-3 are essential for the viability of the DT40 chicken B cell line J Biol Chem 2000, 275:16191-16201 10.1074/jbc.M908066199 10748092
29. de Ruijter AJ Meinsma RJ Bosma P Kemp S Caron HN van Kuilenburg AB Gene expression profiling in response to the histone deacetylase inhibitor BL1521 in neuroblastoma Exp Cell Res 2005, 309:451-467 10.1016/ j.yexcr.2005.06.024 16084510
30. Moore PS Barbi S Donadelli M Costanzo C Bassi C Palmieri M Scarpa A Gene expression profiling after treatment with the histone deacetylase inhibitor trichostatin A reveals altered expression of both pro- and anti-apoptotic genes in pancreatic adenocarcinoma cells Biochim Biophys Acta 2004, 1693:167-176 10.1016/j.bbamcr.2004.07.001 15363630
31. Peart MJ Smyth GK van Laar RK Bowtell DD Richon VM Marks PA Holloway AJ Johnstone RW Identification and functional significance of genes regulated by structurally different histone deacetylase inhibitors Proc Natl Acad Sci USA 2005, 102:3697-3702 552783 15738394 10.1073/ pnas.0500369102
32. Whetstine JR Ceron J Ladd B Dufourcq P Reinke V Shi Y Regulation of tissue-specific and extracellular matrix-related genes by a class I histone deacetylase Mol Cell 2005, 18:483-490 10.1016/ j.molcel.2005.04.006 15893731
33. Zupkovitz G Tischler J Posch M Sadzak I Ramsauer K Egger G Grausenburger R Schweifer N Chiocca S Decker T Seiser C Negative and positive regulation of gene expression by mouse histone deacetylase 1 Mol Cell Biol 2006, 26:7913-7928 1636735 16940178 10.1128/MCB.01220-06
34. Foglietti C Filocamo G Cundari E De RE Lahm A Cortese R Steinkuhler C Dissecting the biological functions of Drosophila histone deacetylases by RNA interference and transcriptional profiling J Biol Chem 2006, 281:17968-17976 10.1074/jbc.M511945200 16632473
35. Mottus R Sobel RE Grigliatti TA Mutational analysis of a histone deacetylase in Drosophila melanogaster: Missense mutations suppress gene silencing associated with position effect variegation Genetics 2000, 154:657-668 1460943 10655219
36. Wu Z Irizarry RA Gentleman R Murillo FM Spencer F A Model Based Background Adjustment for Oligonucleotide Expression Arrays Technical Report, John Hopkins University, Department of Biostatistics Working Papers 2003
37. Smyth GK Linear models and empirical bayes methods for assessing differential expression in microarray experiments Stat Appl Genet Mol Biol 2004, 3 Article 3 16646809
38. Benjamini Y Hochberg Y Controlling the false discovery rate: A practical and powerful approach to multiple testing J R Statist Soc B 1995, 57:289-300
39. Smid M Dorssers LC Jenster G Venn Mapping: Clustering of heterologous microarray data based on the number of co-occurring differentially expressed genes Bioinformatics 2003, 19:2065-2071 10.1093/bioinformatics/ btg282 14594711
40. Peirson SN Butler JN Foster RG Experimental validation of novel and conventional approaches to quantitative real-time PCR data analysis Nucleic Acids Res 2003, 31:e73 167648 12853650 10.1093/nar/gng073
41. Simon RM Korn EL McShane LM Radmacher MD Wright GW Zhao Y Design and analysis of DNA microarray investigations New York: Springer 2003